Status:
RECRUITING
The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Covenant Health, Canada
Alberta Health services
Conditions:
Neonatal Abstinence Syndrome
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Neonatal Abstinence Syndrome (NAS), is a common and costly problem in Alberta that affects approximately 250 babies per year exposed to drugs during pregnancy. Unfortunately, this has become more comm...
Detailed Description
This is a Stepped Wedge-Cluster Randomized Controlled Trial (SW-cRCT) of 8 hospitals with NICUs and post-partum/pediatric units. The SW-cRCT is ideally suited to interventions that require implementat...
Eligibility Criteria
Inclusion
- Infants born at \>36 weeks gestation to mothers who report opiate use during pregnancy (or who are in an ODP/VODP program) and who are admitted to a participating implementation project hospital.
Exclusion
- Infants born at less than 36 weeks and/or birth weight less than 2000 grams and infants with congenital anomalies will be excluded as these infants would be expected to be admitted to NICU.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05226624
Start Date
October 1 2023
End Date
November 30 2026
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2C8